Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

Abroad (travel likely)RecruitingPHASE1

Conditions

Hepatitis D, Chronic · Hepatitis B Chronic Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Aarhus University Hospital, Aarhus, Denmark
Contact: Study coordinator (Henriette Vendelbo Graversen, MD) · henrgv@rm.dk · +45 51 49 25 95
Charité - Universitätsmedizin Berlin, Berlin, Germany
Contact: Study coordinator (Christian Gaebler, Professor) · christian.gaebler@charite.de · xxxxxxxx

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Patients With Liver Disease

Hepatitis D · Hepatitis C · Hepatitis B

Abroad (travel likely)Recruiting

Bethesda, United States

Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

HEPATITIS B CHRONIC · Hepatitis D · Periodontitis

Abroad (travel likely)Recruiting

Craiova, Romania · Craiova, Romania

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

Hepatitis D

Abroad (travel likely)Recruiting

Milan, Italy

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Hepatitis D, Chronic · Hepatitis B, Chronic

Abroad (travel likely)Recruiting

Angers, France · Annecy, France